11 Oct 2017 --- Kerry Group has confirmed the acquisition of US-based technology and innovation company Ganeden at a Capital Markets presentation, which is being held today. The presentation also updates the group’s medium-term growth targets and objectives. Kerry points out that the newly acquired probiotics manufacturer Ganeden, based in Cleveland, Ohio, with current year revenue of approximately US$25m, has an extensive library of published studies and more than 135 patents for technologies in the supplement, food, beverage, nutrition and personal care markets.
